The at-home FluMist vaccine will be for patients ages 2 to 49 years old. Patients can place an order online, complete a ...
The FDA recently approved the first at-home vaccine to prevent influenza, the nasal spray FluMist, which was originally approved in 2003 but only to be administered by doctors. FluMist works just ...
Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...
FluMist was first approved for at-home use in September by the U.S. Food ... If you have plans to get FluMist nasal spray, you should not take any antiviral medication for at least two weeks ...
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...
MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...